In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Ivo Petrov
Speaker
Ivo Petrov

Acibadem City Clinic Cardiovascular Center University Hospital, Sofia (Bulgaria)

Specialities : Interventional Cardiology , Aortic Disease, Stroke

High-end technology in favor of medical humanism

Ivo Petrov, MD, PhD, FESC, FACC is Professor of cardiology at the University of Sofia. He received his postgraduate specialty of Interventional cardioangiology from the University of Buenos Aires, Argentina (2001). He is one of the pioneers of endovascular therapy in Bulgaria (actual president of the Bulgarian society of endovascular therapy). After 2001 he introduced in Bulgaria interventional treatment of carotid stenosis, ischemic stroke, aortic dissection, aortic aneurysm, coronary rotablation, percutaneous recanalization of Lerisch syndrome, renal denervation. He served as national PI in numerous scientific clinical projects. Prof. Ivo Petrov is one of the leading specialists in endovascular treatment of complex aortic pathology and introduced for the first time in the world endovascular treatment of children with aortic dissection and was one of the first to treat by total endovascular approach patients with type A aortic dissection, and subtotal carotid stenosis.

1 presentation from this speaker

Chronic type B dissection in Marfan's disease

Congress : ESC Congress 2017

  • Session : The dissected aorta: confronting guidelines with practice
  • Speaker : I Petrov (Sofia,BG)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are